Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Ana Esther Gabarda Ortega has worked on the following 20 EPO patent applications which have been published in the last five years:

EP11785381

SUBSTITUTED CARBAMOYLCYCLOALKYL ACETIC ACID DERIVATIVES AS NEP INHIBITORS

IPC classification:
A61K 31/192, A61K 31/216, A61K 31/341, A61K 31/40, A61K 31/437, A61K 31/4402, A61P 9/08, C07C 235/36, C07C 235/40, C07D 207/16, C07D 213/55, C07D 235/00, C07D 257/04, C07D 307/52
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11790902

SUBSTITUTED AMINO BISPHENYL PENTANOIC ACID DERIVATIVES AS NEP INHIBITORS

IPC classification:
A61K 31/192, A61K 31/216, A61P 9/08, C07C 235/70
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP12710792

TETRASUBSTITUTED CYCLOHEXYL COMPOUNDS AS KINASE INHIBITORS

IPC classification:
A61K 31/444, A61P 35/00, C07D 213/81, C07D 401/14, C07D 405/14, C07D 417/12, C07D 417/14
Applicant:
Novartis AG
Agent:
Ana Esther Gabarda Ortega, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12709966

NOVEL KINASE INHIBITORS

IPC classification:
A61K 31/444, A61P 35/00, A61P 37/00, C07D 213/75, C07D 401/14, C07D 405/14, C07D 409/14, C07D 413/14
Applicant:
Novartis AG
Agent:
Ana Esther Gabarda Ortega, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12713354

COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATORS AND mGluR5 ANTAGONISTS FOR USE IN DOPAMINE INDUCED DYSKINESIA IN PARKINSON'S DISEASE

IPC classification:
A61K 31/44, A61K 31/4748, A61K 45/06, A61P 25/16
Applicant:
Novartis AG
Agent:
Appleyard Lees Ltd
Agent:
Ana Esther Gabarda Ortega, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP12735521

SALTS OF AZA-BICYCLIC DI-ARYL ETHERS AND METHODS TO MAKE THEM OR THEIR PRECURSORS

IPC classification:
A61K 31/439, A61P 25/16, A61P 25/18, A61P 25/22, A61P 25/24, A61P 25/28, C07D 453/02
Applicant:
Novartis AG
Agent:
Jennifer Delaney, Appleyard Lees Ltd
Agent:
Ana Esther Gabarda Ortega, Novartis Pharma AG
Status:
PATENT GRANTED
EP12795066

CARBAMATE/ UREA DERIVATIVES CONTAINING PIPERIDIN AND PIPERAZIN RINGS AS H3 RECEPTOR INHIBITORS

IPC classification:
A61K 31/496, A61P 25/00, C07D 211/46, C07D 401/04, C07D 401/14, C07D 417/04, C07D 417/14, C07D 487/04
Applicant:
Novartis AG
Agent:
Ana Esther Gabarda Ortega, Novartis Pharma AG
Status:
PATENT GRANTED
EP14155848

Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors

IPC classification:
A61K 31/41, A61K 31/415, A61K 31/42, A61P 7/10, C07D 231/40, C07D 257/06, C07D 261/14
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP13770709

CARBAMATE/UREA DERIVATIVES

IPC classification:
A61K 31/4545, A61P 25/00, C07D 401/04, C07D 401/14
Applicant:
Novartis AG
Agent:
Ana Esther Gabarda Ortega, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13783671

DIAZEPINONE DERIVATIVES USEFUL FOR THE TREATMENT OF FRAGILE X SYNDROME, PARKINSONS OR REFLUX DISEASE

IPC classification:
A61K 31/551, A61P 1/04, A61P 25/16, A61P 25/28, C07D 471/04
Applicant:
Novartis AG
Agent:
Ana Esther Gabarda Ortega, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14707887

SUBSTITUTED BISPHENYL BUTANOIC PHOSPHONIC ACID DERIVATIVES AS NEP (NEUTRAL ENDOPEPTIDASE) INHIBITORS

IPC classification:
A61K 31/66, A61P 9/00, A61P 25/00, C07F 9/38
Applicant:
Novartis AG
Agent:
Ana Esther Gabarda Ortega, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP14707056

SUBSTITUTED BISPHENYL BUTANOIC ACID DERIVATIVES AS NEP INHIBITORS WITH IMPROVED IN VIVO EFFICACY

IPC classification:
A61K 31/4245, A61P 9/00, A61P 11/00, A61P 13/00, A61P 25/00, A61P 29/00, C07D 271/113
Applicant:
Novartis AG
Agent:
Ana Esther Gabarda Ortega, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11784638

METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY

IPC classification:
A61K 31/192, A61K 31/194, A61K 31/197, A61K 31/198, A61K 31/216, A61K 31/235, A61K 31/265, A61K 31/335, A61K 31/34, A61K 31/35, A61K 31/381, A61K 31/40, A61K 31/41, A61K 31/42, A61K 31/44, A61K 31/505, A61K 31/513, A61K 31/5375, A61K 31/55, A61K 45/06, A61P 13/12
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14766806

AUTOTAXIN INHIBITORS COMPRISING A HETEROAROMATIC RING-BENZYL-AMIDE-CYCLE CORE

IPC classification:
A61K 31/41, A61K 31/4245, A61K 31/427, A61K 31/4439, A61K 31/497, A61K 31/506, A61K 31/5377, A61K 31/5513, C07D 401/10, C07D 401/12, C07D 401/14, C07D 403/10, C07D 403/12, C07D 403/14, C07D 413/14
Applicant:
Novartis AG
Agent:
Ana Esther Gabarda Ortega, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14766209

AUTOTAXIN INHIBITORS

IPC classification:
A61K 31/41, A61P 35/00, C07D 257/04, C07D 401/12, C07D 403/12, C07D 405/12, C07D 413/12, C07D 417/12
Applicant:
Novartis AG
Agent:
Ana Esther Gabarda Ortega, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP14792587

COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF MEK

IPC classification:
A61K 31/437, A61P 35/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Ana Esther Gabarda Ortega, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP16154129

SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS

IPC classification:
A61K 31/194, C07C 235/52, C07C 271/12, C07C 275/16, C07C 311/19, C07C 317/44, C07D 213/81, C07D 213/82, C07D 231/14, C07D 239/28, C07D 257/06, C07D 261/18, C07D 309/40, C07D 333/24, C07D 333/40
Applicant:
Novartis AG
Agent:
Ana Esther Gabarda Ortega, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP13151792

Substituted aminopropionic derivatives as neprilysin inhibitors

IPC classification:
A61K 31/21, A61K 31/435, C07C 233/47, C07D 213/82, C07D 239/36, C07D 261/18, C07D 271/06
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP13151795

Substituted aminopropionic derivatives as neprilysin inhibitors

IPC classification:
A61K 31/21, A61K 31/435, C07C 233/47, C07D 213/82, C07D 239/36, C07D 261/18, C07D 271/06
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP15720471

AUTOTAXIN INHIBITORS

IPC classification:
A61K 31/445, A61K 31/4468, A61K 31/454, A61P 3/00, A61P 11/00, A61P 29/00, A61P 35/00, C07D 211/26, C07D 211/34, C07D 211/58, C07D 249/04, C07D 263/38, C07D 265/30, C07D 401/06, C07D 401/12, C07D 403/12, C07D 413/12, C07D 417/12, C07D 451/04
Applicant:
Novartis AG
Agent:
Ana Esther Gabarda Ortega, Novartis Pharma AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature